Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-06-27 08:57 am Purchase |
2022-06-17 | 13G | ToughBuilt Industries, Inc. TBLT |
Mitchell P. Kopin | 6,635 9.990% |
6,635 (New Position) |
Filing History |
| 2022-06-14 06:01 am Purchase |
2022-06-07 | 13G | AIkido Pharma Inc. AIKI |
Mitchell P. Kopin | 223,082 4.200% |
190,746 (+589.89%) |
Filing History |
| 2022-05-27 4:03 pm Purchase |
2022-05-17 | 13G | Baudax Bio, Inc. BXRX |
Mitchell P. Kopin | 10,595 4.990% |
9,259 (+692.98%) |
Filing History |
| 2022-02-28 4:11 pm Purchase |
2022-02-18 | 13G | Guardion Health Sciences, Inc. GHSI |
Mitchell P. Kopin | 250,000,000 8.100% |
250,000,000 (New Position) |
Filing History |
| 2022-02-11 08:18 am Purchase |
2021-12-31 | 13G | Tian Ruixiang Holdings Ltd TIRX |
Mitchell P. Kopin | 51,526 9.990% |
11,335 (+28.20%) |
Filing History |
| 2022-02-11 08:15 am Purchase |
2021-12-31 | 13G | SOS Limited SOS |
Mitchell P. Kopin | 2,396,590 4.900% |
1,041,241 (+76.82%) |
Filing History |
| 2022-02-11 08:11 am Purchase |
2021-12-31 | 13G | Synaptogenix, Inc. SNPX |
Mitchell P. Kopin | 29,614 9.990% |
7,866 (+36.17%) |
Filing History |
| 2022-02-11 08:08 am Sale |
2021-12-31 | 13G | SenesTech, Inc. SNES |
Mitchell P. Kopin | 125 2.400% |
-218 (-63.63%) |
Filing History |
| 2022-02-11 08:06 am Sale |
2021-12-31 | 13G | ReWalk Robotics Ltd. LFWD |
Mitchell P. Kopin | 340,754 3.700% |
-21,709 (-5.99%) |
Filing History |
| 2022-02-11 08:04 am Purchase |
2021-12-31 | 13G | Arcadia Biosciences, Inc. RKDA |
Mitchell P. Kopin | 26,464 4.600% |
7,831 (+42.03%) |
Filing History |
| 2022-02-11 07:56 am Purchase |
2021-12-31 | 13G | Pulmatrix, Inc. PULM |
Mitchell P. Kopin | 167,077 5.600% |
48,577 (+40.99%) |
Filing History |
| 2022-02-11 07:54 am Purchase |
2021-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI |
Mitchell P. Kopin | 160,167 7.200% |
102,266 (+176.62%) |
Filing History |
| 2022-02-11 07:53 am Unchanged |
2021-12-31 | 13G | Plus Therapeutics, Inc. PSTV |
Mitchell P. Kopin | 20,000 1.900% |
0 (Unchanged) |
Filing History |
| 2022-02-11 07:50 am Sale |
2021-12-31 | 13G | Predictive Oncology Inc. POAI |
Mitchell P. Kopin | 119,173 3.500% |
-54,674 (-31.45%) |
Filing History |
| 2022-02-11 07:49 am Purchase |
2021-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Mitchell P. Kopin | 1,231,482 5.600% |
168,272 (+15.83%) |
Filing History |
| 2022-02-11 07:46 am Purchase |
2021-12-31 | 13G | Phio Pharmaceuticals Corp. PHIO |
Mitchell P. Kopin | 7,517 5.700% |
3,393 (+82.28%) |
Filing History |
| 2022-02-11 07:44 am Purchase |
2021-12-31 | 13G | Palisade Bio, Inc. PALI |
Mitchell P. Kopin | 262 1.400% |
262 (New Position) |
Filing History |
| 2022-02-11 07:39 am Purchase |
2021-12-31 | 13G | enVVeno Medical Corporation NVNO |
Mitchell P. Kopin | 431,213 4.400% |
431,213 (New Position) |
Filing History |
| 2022-02-11 07:36 am Unchanged |
2021-12-31 | 13G | Vyant Bio, Inc. VYNT |
Mitchell P. Kopin | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2022-02-11 07:24 am Sale |
2021-12-31 | 13G | InVivo Therapeutics Holdings Corporation NVIVQ |
Mitchell P. Kopin | 34,597 2.500% |
-27,631 (-44.40%) |
Filing History |